HomeTechLeadershipVentureFortune InsidersMost Powerful WomenAutomotiveCareersEnergy & EnvironmentExecutive TravelFinanceHealthinternationalRetailMarketsMagazineNewslettersVideosFortune Conferences

SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Brand Index Methodology

The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.

Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.

Chris Ratcliffe — Bloomberg via Getty Images

54

Pfizer

PFE
 

Pfizer landed one of 2016’s most sought-after biopharma deals with its $14 billion acquisition of cancer drug maker Medivation, beating out the likes of Sanofi. In another critical business decision, the firm announced last fall that it wouldn’t split into two publicly traded companies in order to separate its generic and branded pharmaceutical businesses, raising the prospect of even more future deals. Pfizer also came under fire over drug price increases including a record $107 million fine by U.K. regulators for hiking an epilepsy treatment’s price by 2,600%.

Looking for leads, investment insights, or competitive intelligence?

GET PREMIUM ACCESS

CEO

Ian C. Read

CEO Title

Chairman & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New York, NY

Website

www.pfizer.com

Years on Fortune 500 List

23

Employees

96,500

Profile provided by S&P Global.
Pfizer is also featured in these fortune lists

World’s Most Admired Companies

#186

Global 500

Pfizer: Fortune 500 RANK HISTORY
 
 
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$52,8248.1%
Profits ($M)$7,215.03.7%
Assets ($M)$171,615
Total Stockholder Equity ($M)$59,544
Market Value — as of March 31, 2017 ($M)$203,725
Profit Ratios
Profit as % of Revenues13.7%
Profits as % of Assets4.2%
Profits as % of Stockholder Equity12.1%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.17
EPS % Change (from 2015)5.4%
EPS % Change (5 year annual rate)-1.6%
EPS % Change (10 year annual rate)-7.9%
Total Return
Total Return to Investors (2016)4.4%
Total Return to Investors (5 year, annualized)12.3%
Total Return to Investors (10 year, annualized)6.8%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Pfizer

Pfizer's Meridian Hit With FDA Warning Over EpiPen Flaws

Warning comes with threat of legal action.

Read More →
The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia

The therapy, Besponsa, treats a rapidly progressing version of the disease.

Read More →
Why Martin Shkreli Won’t Be the Last Pharma Bro

Price gouging isn’t going away anytime soon.

Read More →
Here's Why Shares in This Former Pfizer Target Are Tanking

AstraZeneca's big cancer immunotherapy bet is off

Read More →
3 Key Takeaways from the World's Biggest Cancer Conference

Promising cancer drugs took center stage at ASCO 2017, which wraps up Tuesday.

Read More →
53
55
Customer ServiceSite MapPrivacy PolicyFeedbackAd ChoicesAdvertisingYour California Privacy RightsReprints & PermissionsTerms of UseCareers
All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc.. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
© 2017 Time Inc. All rights reserved. Fortune.com is a part of the Time.com network of sites.